Study of Magrolimab in Patients With Solid Tumors
Clinical trial NCT04827576 · TERMINATED
Trial details
- NCT number
- NCT04827576
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2024-10-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.